Ivanovo State University of Chemistry and Technology, 153000 Ivanovo, Russia; G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, 153045 Ivanovo, Russia.
Ivanovo State University of Chemistry and Technology, 153000 Ivanovo, Russia.
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Oct 15;279:121403. doi: 10.1016/j.saa.2022.121403. Epub 2022 May 17.
The coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 coronavirus has spread rapidly around the world in a matter of weeks. Most of the current recommendations developed for the use of antivirals in COVID-19 were developed during the initial waves of the pandemic, when resources were limited and administrative or pragmatic criteria took precedence. The choice of drugs for the treatment of COVID-19 was carried out from drugs approved for medical use. COVID-19 is a serious public health problem and the search for drugs that can relieve the disease in infected patients at various stages is still necessary. Therefore, the search for effective drugs with inhibitory and/or virucidal activity is a paramount task. Accessory proteins of the virus play a significant role in the pathogenesis of the disease, as they modulate the host's immune response. This paper studied the interaction of one of the SARS-CoV-2 accessory proteins ORF10 with macroheterocyclic compounds - protoporphyrin IX d.m.e., Fe(III)protoporphyrin d.m.e. and 5,10,15,20-tetrakis(3'-pyridyl)chlorin tetraiodide, which are potential inhibitors and virucidal agents. The SARS-CoV-2 ORF10 protein shows the highest affinity for Chlorin, which binds hydrophobically to the alpha structured region of the protein. Protoporphyrin is able to form several complexes with ORF10 close in energy, with alpha- and beta-molecular recognition features, while Fe(III)protoporphyrin forms complexes with the orientation of the porphyrin macrocycle parallel to the ORF10 alpha-helix. Taking into account the nature of the interaction with ORF10, it has been suggested that Chlorin may have virucidal activity upon photoexposure. The SARS-CoV-2 ORF10 protein was expressed in Escherichia coli cells, macroheterocyclic compounds were synthesized, and the structure was confirmed. The interaction between macrocycles with ORF10 was studied by spectral methods. The results of in silico studies were confirmed by experimental data.
由严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起的 2019 年冠状病毒病(COVID-19)在数周内迅速在全球范围内传播。目前大多数针对 COVID-19 抗病毒药物使用的建议是在大流行的初始阶段制定的,当时资源有限,行政或务实标准优先。COVID-19 治疗药物的选择是从已批准用于医疗用途的药物中进行的。COVID-19 是一个严重的公共卫生问题,仍然需要寻找可缓解感染患者各个阶段疾病的药物。因此,寻找具有抑制和/或抗病毒活性的有效药物是当务之急。病毒的辅助蛋白在疾病发病机制中起着重要作用,因为它们调节宿主的免疫反应。本文研究了 SARS-CoV-2 辅助蛋白 ORF10 与宏杂环化合物 - 原卟啉 IX d.m.e.、Fe(III)原卟啉 d.m.e. 和 5,10,15,20-四(3'-吡啶基)氯代卟啉四碘化物的相互作用,这些化合物是潜在的抑制剂和抗病毒剂。SARS-CoV-2 ORF10 蛋白对 Chlorin 表现出最高的亲和力,Chlorin 与蛋白的 alpha 结构域疏水性结合。原卟啉能够与 ORF10 形成几个能量相近的复合物,具有 alpha-和 beta-分子识别特征,而 Fe(III)原卟啉则与原卟啉大环的取向形成复合物与 ORF10 alpha-螺旋平行。考虑到与 ORF10 的相互作用性质,有人提出 Chlorin 在光暴露下可能具有抗病毒活性。SARS-CoV-2 ORF10 蛋白在大肠杆菌细胞中表达,合成了宏杂环化合物,并确认了其结构。通过光谱方法研究了大环与 ORF10 的相互作用。通过实验数据证实了计算机模拟研究的结果。